Microbiota encoded fatty-acid metabolism expands tuft cells to protect tissues homeostasis during Clostridioides difficile infection in the large intestine
Authors:
- Benedikt M. MortzfeldBMBenedikt M. Mortzfeld
- Sage E. FoleySFSage E. Foley
- Doyle V. WardDWDoyle V. Ward
- Beth A. McCormickBMBeth A. McCormick
- Andrea ReboldiARAndrea Reboldi
- Vanni BucciVBVanni Bucci
Preprint
Abstract
Metabolic byproducts of the intestinal microbiota are crucial in maintaining host immune tone and shaping inter-species ecological dynamics. Among these metabolites, succinate is a driver of tuft cell (TC) differentiation and consequent type 2 immunity-dependent protection against invading parasites in the small intestine. Succinate is also a growth enhancer of the nosocomial pathogen Clostridioides difficile in the large intestine. To date, no research has shown the role of succinate in modulating TC dynamics in the large intestine, or the relevance of this immune pathway to C. difficile pathophysiology. Here we reveal the existence of a three-way circuit between commensal microbes, C. difficile and host epithelial cells which centers around succinate. Through selective microbiota depletion experiments we demonstrate higher levels of type 2 cytokines leading to expansion of TCs in the colon. We then demonstrate the causal role of the microbiome in modulating colonic TC abundance and subsequent type 2 cytokine induction using rational supplementation experiments with fecal transplants and microbial consortia of succinate-producing bacteria. We show that administration of a succinate-deficient Bacteroides thetaiotaomicron knockout (Δfrd) significantly reduces the enhanced type 2 immunity in mono-colonized mice. Finally, we demonstrate that mice prophylactically administered with the consortium of succinate-producing bacteria show reduced C. difficile -induced morbidity and mortality compared to mice administered with heat-killed bacteria or the vehicle. This effect is reduced in a partial tuft cell knockout mouse, Pou2f3 +/- , and nullified in the tuft cell knockout mouse, Pou2f3 -/- , confirming that the observed protection occurs via the TC pathway. Succinate is an intermediary metabolite of the production of short-chain fatty acids, and its concentration often increases during dysbiosis. The first barrier to enteric pathogens alike is the intestinal epithelial barrier, and host maintenance and strengthening of barrier integrity is vital to homeostasis. Considering our data, we propose that activation of TC by the microbiota-produced succinate in the colon is a mechanism evolved by the host to counterbalance microbiome-derived cues that facilitate invasion by intestinal pathogens.Keywords
This publication has 63 references indexed in Scilit:
- An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography–tandem mass spectrometryAnalytica Chimica Acta, 2015
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileNature, 2014
- Bile acids and the gut microbiomeCurrent Opinion in Gastroenterology, 2014
- Succinate: a metabolic signal in inflammationTrends in Cell Biology, 2014
- Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generationNature, 2013
- Treg induction by a rationally selected mixture of Clostridia strains from the human microbiotaNature, 2013
- Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium ColonizationInfection and Immunity, 2013
- IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Cefoperazone-treated mice as an experimental platform to assess differential virulence ofClostridium difficilestrainsGut Microbes, 2011
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium SpeciesScience, 2011